Effects of aging and cyclosporin treatment on the hepatobiliary efflux of glutathione

Life Sciences

Volumn 73, Issue 26, 2003, Pages 3387-3397

  Palomero, J ^a   Galan A I ^a   Munoz M E ^a   Tunon M J ^b   Gonzalez Gallego J ^b   Jimenez R ^a,c  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF LEÓN   (Spain)

^c Campus M de Unamuno   (Spain)

Author keywords

Aging; Biliary glutathione; Cyclosporin A; Free radicals; Liver glutathione

Indexed keywords

ACIVICIN; CYCLOSPORIN A; GLUTATHIONE; GLUTATHIONE DISULFIDE; TRIPEPTIDE;

AGED; AGING; ANIMAL TISSUE; ARTICLE; BILE; BILE FLOW; CATABOLISM; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; DRUG MECHANISM; HEPATOBILIARY SYSTEM; INHIBITION KINETICS; LIVER FUNCTION; LIVER LEVEL; MALE; NONHUMAN; OXIDATION; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN SECRETION; PROTEIN TRANSPORT; RAT; REDUCTION;

ANIMALIA;

EID: 0142219741     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.06.019     Document Type: Article

References (35)

1. Ballatori N., Jacob R., Barret C., Boyer J.L. Biliary catabolism of glutathione and differential reabsorption of its aminoacid constituents. American Journal of Physiology. 254:1988;1-7.
2. Ballatori N., Jacob R., Boyer J.L. Intrabiliary glutathione hydrolisis. A source of glutamate in bile. Journal of Biological Chemistry. 261:1986;7860-7865.
3. Ballatori N., Rebbeor J.F. Role of MRP2 and oatp1 in hepatocellular export of reduced glutathione. Seminars in Liver Diseases. 18:1997;377-387.
4. Ballatori N., Truong A.T. Glutathione as a primary osmotic driving force in hepatic bile formation. American Journal of Physiology. 263:1992;G617-G624.
5. Ballatori N., Truong A.T. Relation between biliary glutathione excretion and bile acid-independent bile flow. American Journal of Physiology. 256:1989;G22-G30.
6. Bohme M., Jedlitschky G., Leier I., Buchler M., Keppler D. ATP-dependent export pumps and their inhibition by cyclosporins. Advances in Enzyme Regulation. 34:1994;371-380.
7. Borel J.F., Baumann G., Chapman I., Donatsch P., Fahr A., Mueller E.A., Vigouret J.M. In vivo pharmacological effects of cyclosporin and some analogues. Advances in Pharmacology. 35:1996;115-246.
8. Bouchard G., Yousef I.M., Tuchweber B. Decreased biliary glutathione content is responsible for the decline in bile salt-independent flow induced by ethynil estradiol in rats. Toxicology Letters. 74:1994;221-233.
9. Bouchard G., Yousef I.M., Barriault C., Tuchweber B. Role of glutathione and oxidative stress in phalloidin-induced cholestasis. Journal of Hepatology. 32:2000;550-560.
10. Bramon S., Ott P., Thomsen Nielsen F., Bangert K., Tygstrup N., Dalhoff K. Cholestasis and regulation of genes related to drug metabolism and biliary transport in rat liver following treatment with cyclosporin and sirolimus (rapamycin). Pharmacology and Toxicology. 89:2001;133-139.
11. Chan F.K.L., Zhang Y., Lee S.S., Shaffer E.A. The effects of liver transplantation and cyclosporine on bile formation and lipid composition: An experimental study in the rat. Journal of Hepatology. 28:1998;329-336.
12. Deleve L.D., Kaplowitz N. Importance and regulation of hepatic glutathione. Seminars in Liver Diseases. 10:1990;251-256.
13. Deters M., Strubelt O., Younes M. Reevaluation of cyclosporine induced hepatotoxicity in the isolated perfused rat liver. Toxicology. 123:1997;197-206.
14. Duruibe V.A., Okonmah A., Blyden G.T. Effect of cyclosporine A on rat liver and kidney glutathione content. Pharmacology. 39:1989;205-212.
15. Fernández E., Galán A.I., Morán D., González-Buitrago J.M., Muñoz M.E., Jiménez R. Reversal of cyclosporine A-induced alterations in biliary secretion by S-adenosyl-L- methionine in rats. Journal of Pharmacology and Experimental Therapeutics. 275:1995;442-449.
16. Galán A.I., Fernández E., Morán D., Muñoz M.E., Jiménez R. Cyclosporine A hepatotoxicity: effect of prolonged treatment with cyclosporine on biliary lipid secretion in the rat. Clinical and Experimental Pharmacology and Physiology. 22:1995;260-265.
17. Galán A.I., Muñoz M.E., Jiménez R. S-adenosylmethionine protects against cyclosporine A-induced alterations in rat liver plasma membrane fluidity and functions. Journal of Pharmacology and Experimental Therapeutics. 290:1999;774-781.
18. Galán A.I., Zapata A.J., Román I.D., Muñoz M.E., González-Gallego J., Jiménez R. Impairment of maximal bilirubin secretion by cyclosporin A in the rat. Archives Internationales de Physiologie de Biochimie et de Biophysique. 99:1991;373-376.
19. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Analytical Biochemistry. 106:1980;207-212.
20. Keppler D., Arias I.M. Hepatic canalicular membrane. Introduction: transport across the hepatocyte canalicular membrane. FASEB Journal. 11:1997;15-18.
21. Kitani K. Drugs and the ageing liver. Life Chemistry Reports. 6:1988;143-230.
22. Lauteburg B.H. Biliary excretion of glutathione and glutathione adducts. Progress in Pharmacology and Clinical Pharmacology. 8:1991;201-213.
23. Morán D., González de Buitrago J.M., Fernández E., Galán A.I., Muñoz M.E., Jiménez R. Inhibition of biliary glutathione secretion by cyclosporine A in the rat: possible mechanisms and role in the cholestasis induced by the drug. Journal of Hepatology. 29:1998;68-77.
24. Muller M., Roelofsen H., Jansen P.L.M. Secretion of organic anions by hepatocytes: involvement of homologues of the multidrug resistence protein. Seminars in Liver Diseases. 16:1996;211-220.
25. Ookhtens M., Kaplowitz N. Role of liver in interorgan homeostasis of glutathione and cysteine. Seminars in Liver Diseases. 18:1998;313-329.
26. Oude Elferink R.P., Ottenhoff R., Van Wuland M., Smit J.M., Schinkel A.H., Groen A.K. Regulation of biliary lipid secretion by mdr2-P-glycoprotein in the mouse. Journal of Clinical Investigation. 95:1995;31-38.
27. Palomero J., Galán A.I., Muñoz M.E., Tuñón M.J., González-Gallego J., Jiménez R. Effects of aging on the suceptibility to the toxic effects of cyclosporin A in rats. Changes in liver glutathione and antioxidant enzymes. Free Radical in Biology & Medicine. 30:2001;836-845.
28. Paulusma C.C., Van Geer M.A., Evers R., Ottenhoff R., Borst P., Oude Elferink R.P. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochemical Journal. 338:1999;393-401.
29. Rikans L.E., Hornbrook K.R. Age-related susceptibility to hepatotoxicants. Environmental Toxicology and Pharmacology. 4:1997;339-344.
30. Rikans L.E., Moore D.R., Hornbrook K.R. Lipid peroxidation, antioxidant protection and aging. Biochemica Biophysica Acta. 1362:1997;116-127.
31. Román I.D., Monte M.J., González-Buitrago J.M., Esteller A., Jiménez R. Inhibition of hepatocytary vesicular transport by cyclosporin A in the rat: relationship with cholestasis and hyperbilirubinemia. Hepatology. 12:1990;83-91.
32. Rost D., Kartenbeck J., Keppler D. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis. Hepatology. 29:1999;814-821.
33. Schade R., Guglielmi A., Van Thiel D.N. Cholestasis in heart transplant recipients treated with cyclosporine. Transplantation Proceedings. 15:1983;2757.
34. Vendemiale G., Grattagliano I., Altomare E. An update on the role of free radicals and antioxidant defense in human disease. International Journal of Clinical Laboratory Research. 29:1999;49-55.
35. Verkade H.J., Vonk R.J., Kuipers F. New insights into the mechanisms of bile acid-induced biliary lipid secretion. Hepatology. 21:1995;1174-1189.